BioArctic AB (publ) (LON:0RV2)
London · Delayed Price · Currency is GBP · Price in SEK 312.32
-2.98 (-0.95%)
At close: Dec 30, 2025
BioArctic AB Market Cap
BioArctic AB has a market cap or net worth of 2.22 billion as of December 31, 2025. Its market cap has increased by 94.83% in one year.
Market Cap
2.22B
Enterprise Value
2.08B
Revenue
151.29M
Ranking
n/a
PE Ratio
28.19
Stock Price
312.32
Market Cap Chart
Since October 12, 2017, BioArctic AB's market cap has increased from 239.49M to 2.22B, an increase of 828.96%. That is a compound annual growth rate of 31.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 2.22B | 74.38% |
| Dec 30, 2024 | 1.28B | -30.70% |
| Dec 29, 2023 | 1.84B | -3.54% |
| Dec 30, 2022 | 1.91B | 121.99% |
| Dec 30, 2021 | 859.79M | 14.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.22B |
| HSBC Holdings | 201.57B |
| Shell | 156.37B |
| Unilever | 107.52B |
| Rio Tinto Group | 102.69B |
| Rolls-Royce Holdings | 96.51B |
| British American Tobacco p.l.c. | 91.15B |
| GSK plc | 73.45B |